Chris Sfouggatakis
About Chris Sfouggatakis
Chris Sfouggatakis is a Senior Principal Scientist at Bristol-Myers Squibb in the Greater New York City Area, with a Ph.D. in Organic Chemistry from the University of Pennsylvania and a B.S. in Chemistry from Fordham University.
Company
Chris Sfouggatakis is currently employed at Bristol-Myers Squibb, where he serves as a Senior Principal Scientist. He operates within the Greater New York City Area, contributing to various scientific and development projects.
Title
As a Senior Principal Scientist at Bristol-Myers Squibb, Chris Sfouggatakis holds a senior-level role involving both leadership and specialized scientific expertise. His responsibilities encompass significant areas of drug development and safety.
Education and Expertise
Chris Sfouggatakis holds a Ph.D. in Organic Chemistry with a focus on Complex Molecule Total Synthesis from the University of Pennsylvania. He completed his doctoral studies over five years from 1999 to 2004. Prior to this, he earned a B.S. in Chemistry, summa cum laude, from Fordham University, where he studied from 1995 to 1999.
Background
In his career, Chris Sfouggatakis has co-chaired key committees, such as the New Modalities Advisory Committee (NMAC) and the Safety Alert Committee (SAC), at Bristol-Myers Squibb. These roles involve developing strategies for new modalities and ensuring safety within Chemical Development.
Achievements
Chris Sfouggatakis has extensive experience in lab-scale route discovery, plant-scale execution, and technology transfer. He has led teams of scientists in early and late-stage development projects and successfully delivered drug substances for clinical evaluations. Additionally, he has contributed to recruiting and hiring Ph.D. level scientists through university relations.